Reduction of Transfusion Burden (TB), Hemoglobin Increase, and Dose Titration in the COMMANDS Study of Luspatercept Versus Epoetin Alfa (EA) in Erythropoietin-Stimulating Agent (ESA)-Naive Patients With Transfusion-Dependent (TD) Lower-Risk Myelodysplastic Syndromes (LR-MDS)

被引:0
|
作者
Komrokji, Rami S. [1 ]
Platzbecker, Uwe [2 ]
Della Porta, Matteo [3 ,4 ]
Santini, Valeria [5 ]
Garcia-Manero, Guillermo [6 ]
Li, Jiahui [7 ]
Zhang, Jennie [7 ]
Giuseppi, Ana Carolina [7 ]
Kreitz, Sandra [8 ]
Pozharskaya, Veronika [7 ]
Keeperman, Karen L. [7 ]
Rose, Shelonitda [7 ]
Hughes, Christina [7 ]
Valcarcel, David [9 ]
Fenaux, Pierre [10 ]
Shortt, Jake [11 ,12 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Dept Hematol Cell Hematol & Hemostaseol, Leipzig, Germany
[3] Canc Ctr IRCCS Humanitas Res Hosp, Milan, Italy
[4] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[5] Univ Florence, AOUC, MDS Unit, Hematol, Florence, Italy
[6] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[7] Bristol Myers Squibb, Princeton, NJ USA
[8] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland
[9] Hosp Univ Vall Hebron, Barcelona, Spain
[10] Univ Paris 07, Hop St Louis, Serv Hematol Seniors, Paris, France
[11] Monash Univ, Melbourne, Vic, Australia
[12] Monash Hlth, Melbourne, Vic, Australia
来源
关键词
MDS; myelodysplastic neoplasms; erythroid response; clinical benefit; RBC transfusion independence; ESA-naive; phase III;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDS-234
引用
收藏
页码:S358 / S359
页数:2
相关论文
共 31 条
  • [31] Efficacy of Imetelstat in Achieving Red Blood Cell Transfusion Independence ( RBC-TI) across Different Risk Subgroups in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis-Stimulating Agents (ESAs) in IMerge Phase 3 Study
    Komrokji, Rami S.
    Santini, Valeria
    Fenaux, Pierre
    Savona, Michael R.
    Madanat, Yazan F.
    Berry, Tymara
    Sherman, Laurie
    Navada, Shyamala
    Feller, Faye M.
    Sun, Libo
    Xia, Qi
    Wan, Ying
    Huang, Fei
    Zeidan, Amer M.
    Platzbecker, Uwe
    BLOOD, 2023, 142